Waldmeier, P C <br/><br/>
CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease.  [electronic resource] 

 -  Naunyn-Schmiedeberg's archives of pharmacology  Dec 2000 
 - 526-37 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0028-1298 
<br/><br/><label>Standard No.: </label>10.1007/s002100000300  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenylpyridinium--toxicity<br/>Animals<br/>Antiparkinson Agents--pharmacology<br/>Brain--drug effects<br/>Cell Culture Techniques<br/>Cell Death--drug effects<br/>Disease Models, Animal<br/>Dopamine--metabolism<br/>Female<br/>Liver--drug effects<br/>Mesencephalon--cytology<br/>Mice<br/>Mice, Inbred C57BL<br/>Monoamine Oxidase--metabolism<br/>Monoamine Oxidase Inhibitors--pharmacology<br/>Neurons--drug effects<br/>Oxepins--pharmacology<br/>Oxidopamine<br/>Parkinsonian Disorders--drug therapy<br/>Pregnancy<br/>Rats<br/>Selegiline--pharmacology<br/>Substantia Nigra--enzymology<br/>Tritium<br/>Tyrosine 3-Monooxygenase--metabolism